---
schema_version: "secwatch.filing_event.v1"
accession: "0001062822-25-000035"
form_type: "8-K"
ticker: "LXRX"
cik: "0001062822"
company_name: "LEXICON PHARMACEUTICALS, INC."
filed_at: "2025-07-03T23:59:59+00:00"
generated_at: "2026-05-18T09:24:32.339852+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Lexicon gets Nasdaq 180-day extension to regain $1 bid; stock moves to Capital Market

## Summary
- Nasdaq granted additional 180-day period until Dec 30, 2025 for Lexicon to cure $1 bid price deficiency.
- Common stock will transfer from Nasdaq Global Select to Capital Market on July 7, 2025.
- Compliance requires closing bid ≥ $1 for ten consecutive business days during the extension period.
- Eligibility conditioned on meeting other listing requirements and intent to pursue reverse stock split if necessary.

## SEC filing metadata
- accession: 0001062822-25-000035
- form_type: 8-K
- ticker: LXRX
- cik: 0001062822
- company_name: LEXICON PHARMACEUTICALS, INC.
- filed_at: 2025-07-03T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1062822/000106282225000035/0001062822-25-000035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1062822/000106282225000035/lxrx-20250703.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062822-25-000035
- JSON: https://secwatch.observer/filing/0001062822-25-000035.json
- Plain text: https://secwatch.observer/filing/0001062822-25-000035.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.